ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,612, issued on June 30, was assigned to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Leiden, Netherlands).

"Oncolytic non-human adenoviruses and uses thereof" was invented by Rob Cornelis Hoeben (Leiden, Netherlands), Selas Bots (Leiden, Netherlands) and Vera Kemp (Leiden, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel nucleic acid sequences, vectors and adenoviral genomes are provided herein. Corresponding novel adenoviruses and genotypes and compositions are also provided. The novel nucleic acid sequences, vectors, genomes, adenoviruses, genotypes and compositions are useful in therapy. The novel nucleic acid sequences, vectors,...